Skip to content

Does topical application of transexamic acid reduce postoperative bleeding in coronary artery bypass graft surgery?

Does topical application of transexamic acid reduce postoperative bleeding in coronary artery bypass graft surgery?

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016071628945N1
Enrollment
120
Registered
2016-10-22
Start date
2016-11-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bleeding. Other postprocedural disorders of circulatory system, not elsewhere classified

Interventions

Intervention 1: Intervention group: patients receiving 1 gram TA diluted in 50 cc normal saline poured into mediastinal cavity before closing the chest. Intervention 2: Control group: patients receivi
Treatment - Drugs
Intervention group: patients receiving 1 gram TA diluted in 50 cc normal saline poured into mediastinal cavity before closing the chest
Control group: patients receiving 50 ml normal saline poured into mediastinal cavity before closing the chest

Sponsors

investigator
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients undergoing CABG surgery alone; interrupting aspirin three days and Plavix at least five days before surgery; lack of consuming any other anticoagulant drugs such as heparin or warfarin; lack of coagulation and bleeding disorders; lack of liver and kidney disease; Ejection fraction> 35%. Exclusion criteria: complex surgery; emergency surgery; anticoagulation therapy before surgery; having hemoglobin lower than 8 grams per deciliter before surgery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Postoperative bleeding. Timepoint: 24 hrs and 48 hrs postoperatively. Method of measurement: drainage in chest tube.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Mirmohammadsadeghi

Isfahan University of Medical Sciences

am_sadeghi@med.mui.ac.ir+98 31 3260 0961

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026